| PEMOE39 | Measuring the impact of the COVID-19 lockdown on testing services in specialized HIV facilities in Mexico | Poster exhibition | Impact of COVID-19 on HIV testing services |
| PEMOE40 | The effects of COVID-19 on HIV care and treatment programs: a multicountry review | Poster exhibition | Impact of COVID-19 on HIV treatment services |
| PEMOE41 | Impact of COVID-19 public health measures on ART use among Ugandans living with HIV in sero-different couples | Poster exhibition | Impact of COVID-19 on HIV treatment services |
| PEMOE42 | Increased prevalence of depression and anxiety among adults initiating antiretroviral therapy during the COVID-19 pandemic in Tanzania | Poster exhibition | Impact of COVID-19 on HIV treatment services |
| PEMOE43 | Describing the impact of COVID-19 on AIDS Drug Assistance Program operations | Poster exhibition | Impact of COVID-19 on HIV treatment services |
| PEMOE44 | Maintaining access to HIV services to persons living with HIV amid the COVID-19 pandemic in Nepal | Poster exhibition | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| PEMOE45 | Building infection prevention and control capacity across PEPFAR programs in response to the COVID-19 pandemic | Poster exhibition | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| PEMOE46 | A pandemic over an epidemic: surveying LGBTQI+ situation during COVID-19 pandemic in Thailand | Poster exhibition | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| PEMOE47 | Analyzing FY 19-21 PEPFAR PrEP uptake focusing on adolescent girls and young women and key populations | Poster exhibition | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| PEMOF25 | Litigating against forced and coerced sterilisation in Kenya | Poster exhibition | Legal advocacy tools and strategies |